[1] Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet, 2015, 386: 1546-1555.
[2] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南 (2010 年版). 中国医学前沿杂志 (电子版), 2011, 3: 66-82.
[3] 夏海珊, 陈少茹, 钟月春, 等. 肝纤维化的发病机制和药物治疗现况. 中国医药导报, 2014, 11: 162-165, 168.
[4] Loomba R, Schork N, Chen CH, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology, 2015, 149: 1784-1793.
[5] 胡锡琪, 张锦生. 肝穿刺活检——肝纤维化的病理诊断实践与理论. 诊断学理论与实践, 2005, 4: 71-74,79.
[6] 欧晓娟, 王晓明, 吴晓宁, 等. FibroTouch 与 FibroScan 在慢性乙型肝炎患者肝纤维化评估中的比较. 中华肝脏病杂志, 2015, 23: 103-106.
[7] 梅玉峰, 熊钻, 刘萍. 慢性乙型肝炎患者 HBV DNA 载量及肝纤维化相关性分析. 临床血液学杂志(输血与检验), 2015, 28: 309-311.
[8] Zhao J, Zhang Z, Luan Y, et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology, 2014, 59: 1331-1342.
[9] Van Linthout S, Miteva K, Tschope C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res, 2014, 102: 258-269.
[10] 陈高峰, 平键, 顾宏图, 等. 慢性乙型肝炎患者 FibroTouch 和 FibroScan 检测肝脏硬度与肝组织学 Ishak 纤维化评分的相关性分析. 中华肝脏病杂志, 2017, 25: 145-150.
[11] Sasso M, Audière S, Kemgang A, et al. Liver steatosis assessed by controlled attenuation parameter (CAP) measured with the XL probe of the FibroScan: a pilot study assessing diagnostic accuracy. Ultrasound Med Biol, 2016, 42: 92-103.
[12] 卢加发, 刘文斌, 潘勤, 等. 健康体检成人 FibroScan 检测肝脏硬度值与受控衰减参数的相关分析. 实用肝脏病杂志, 2014, 17: 484-489.
[13] Foucher J, Castéra L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol, 2006, 18: 411-412. |
